ITM support for patients with chronic respiratory and cardiovascular diseases: A protocol for a randomised controlled trial

Julie Redfern; Karice Hyun; Anna Singleton; Nashid Hafiz; Rebecca Raeside; Lissa Spencer; Bridie Carr; Ian Caterson; John Cullen; Cate Ferry; Karla Santo; Alison Hayes; Regina W.M. Leung; Simon Raadsma; Jessica Swinbourne; Jin G. Cho; Meredith King; Mary Roberts; Cindy Kok; Christine Jenkins; Clara Chow

doi:10.1136/bmjopen-2018-023863

ITM support for patients with chronic respiratory and cardiovascular diseases: A protocol for a randomised controlled trial

Julie Redfern^*, Karice Hyun, Anna Singleton, Nashid Hafiz, Rebecca Raeside, Lissa Spencer, Bridie Carr, Ian Caterson, John Cullen, Cate Ferry, Karla Santo, Alison Hayes, Regina W.M. Leung, Simon Raadsma, Jessica Swinbourne, Jin G. Cho, Meredith King, Mary Roberts, Cindy Kok, Christine JenkinsClara Chow

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

10 Citations (Scopus)

13 Downloads (Pure)

Abstract

Introduction:

Simple and scalable strategies are needed to improve a € out-of-hospital' support and management for people living with cardiovascular disease (CVD) and respiratory disease. Text messaging via mobile phones has been shown to be effective in helping promote lifestyle change and is supported by quantitative and qualitative evidence. The aim of this study is to test the effectiveness and implementation of a 6-month text messaging support programme for people with CVD and respiratory disease as an addition to cardiac and pulmonary outpatient rehabilitation.

Methods and analysis:

Pragmatic randomised controlled trial (n=310) to test the effectiveness of a 6-month text message support programme on clinical outcomes in people with CVD and chronic respiratory disease who are attending outpatient cardiac and pulmonary rehabilitation. The study includes a nested process evaluation to inform scalability and implementation across settings. The intervention group will receive a text message support programme comprising five messages per week for 26 weeks and the control group will continue with standard care. The primary outcome is exercise capacity (6 min walk distance). Secondary outcomes include clinical measures (proportion of people meeting the Australian guideline-recommended blood pressure and cholesterol targets), lifestyle outcomes (smoking rates, achievement of national guidelines for nutrition and physical activity), quality of life, mood (Hospital Anxiety and Depression Scale), medication adherence and attendance at and completion of rehabilitation.

Ethics and dissemination:

Primary ethics approval was received from the Sydney Local Health District Hospital Human Research Ethics Committee and associated Governance committees at sites. Results will be disseminated via the usual scientific forums including peer-reviewed publications and presentations at international conferences. At its conclusion, the study will determine the effectiveness and implementation of a simple programme that aims to improve health outcomes and attendance at rehabilitation for people with CVD and chronic respiratory disease. Trial registration number ACTRN12616001167459.

Original language	English
Article number	023863
Pages (from-to)	1-7
Number of pages	7
Journal	BMJ Open
Volume	9
Issue number	3
DOIs	https://doi.org/10.1136/bmjopen-2018-023863
Publication status	Published - 1 Mar 2019
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/bmjopen-2018-023863Licence: CC BY-NC

ITM support for patients with chronic respiratory and cardiovascular diseases A protocol for a randomised controlled trialFinal published version, 563 KBLicence: CC BY-NC

Cite this

Redfern, J., Hyun, K., Singleton, A., Hafiz, N., Raeside, R., Spencer, L., Carr, B., Caterson, I., Cullen, J., Ferry, C., Santo, K., Hayes, A., Leung, R. W. M., Raadsma, S., Swinbourne, J., Cho, J. G., King, M., Roberts, M., Kok, C., ... Chow, C. (2019). ITM support for patients with chronic respiratory and cardiovascular diseases: A protocol for a randomised controlled trial. BMJ Open, 9(3), 1-7. Article 023863. https://doi.org/10.1136/bmjopen-2018-023863

@article{e2595ac9b01541eab270a239a5bee08e,

title = "ITM support for patients with chronic respiratory and cardiovascular diseases: A protocol for a randomised controlled trial",

abstract = "Introduction:Simple and scalable strategies are needed to improve a € out-of-hospital' support and management for people living with cardiovascular disease (CVD) and respiratory disease. Text messaging via mobile phones has been shown to be effective in helping promote lifestyle change and is supported by quantitative and qualitative evidence. The aim of this study is to test the effectiveness and implementation of a 6-month text messaging support programme for people with CVD and respiratory disease as an addition to cardiac and pulmonary outpatient rehabilitation.Methods and analysis:Pragmatic randomised controlled trial (n=310) to test the effectiveness of a 6-month text message support programme on clinical outcomes in people with CVD and chronic respiratory disease who are attending outpatient cardiac and pulmonary rehabilitation. The study includes a nested process evaluation to inform scalability and implementation across settings. The intervention group will receive a text message support programme comprising five messages per week for 26 weeks and the control group will continue with standard care. The primary outcome is exercise capacity (6 min walk distance). Secondary outcomes include clinical measures (proportion of people meeting the Australian guideline-recommended blood pressure and cholesterol targets), lifestyle outcomes (smoking rates, achievement of national guidelines for nutrition and physical activity), quality of life, mood (Hospital Anxiety and Depression Scale), medication adherence and attendance at and completion of rehabilitation. Ethics and dissemination:Primary ethics approval was received from the Sydney Local Health District Hospital Human Research Ethics Committee and associated Governance committees at sites. Results will be disseminated via the usual scientific forums including peer-reviewed publications and presentations at international conferences. At its conclusion, the study will determine the effectiveness and implementation of a simple programme that aims to improve health outcomes and attendance at rehabilitation for people with CVD and chronic respiratory disease. Trial registration number ACTRN12616001167459.",

author = "Julie Redfern and Karice Hyun and Anna Singleton and Nashid Hafiz and Rebecca Raeside and Lissa Spencer and Bridie Carr and Ian Caterson and John Cullen and Cate Ferry and Karla Santo and Alison Hayes and Leung, {Regina W.M.} and Simon Raadsma and Jessica Swinbourne and Cho, {Jin G.} and Meredith King and Mary Roberts and Cindy Kok and Christine Jenkins and Clara Chow",

note = "Publisher Copyright: {\textcopyright} Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.",

year = "2019",

month = mar,

day = "1",

doi = "10.1136/bmjopen-2018-023863",

language = "English",

volume = "9",

pages = "1--7",

journal = "BMJ Open",

issn = "2044-6055",

publisher = "BMJ Publishing Group",

number = "3",

}

Redfern, J, Hyun, K, Singleton, A, Hafiz, N, Raeside, R, Spencer, L, Carr, B, Caterson, I, Cullen, J, Ferry, C, Santo, K, Hayes, A, Leung, RWM, Raadsma, S, Swinbourne, J, Cho, JG, King, M, Roberts, M, Kok, C, Jenkins, C & Chow, C 2019, 'ITM support for patients with chronic respiratory and cardiovascular diseases: A protocol for a randomised controlled trial', BMJ Open, vol. 9, no. 3, 023863, pp. 1-7. https://doi.org/10.1136/bmjopen-2018-023863

TY - JOUR

T1 - ITM support for patients with chronic respiratory and cardiovascular diseases: A protocol for a randomised controlled trial

AU - Redfern, Julie

AU - Hyun, Karice

AU - Singleton, Anna

AU - Hafiz, Nashid

AU - Raeside, Rebecca

AU - Spencer, Lissa

AU - Carr, Bridie

AU - Caterson, Ian

AU - Cullen, John

AU - Ferry, Cate

AU - Santo, Karla

AU - Hayes, Alison

AU - Leung, Regina W.M.

AU - Raadsma, Simon

AU - Swinbourne, Jessica

AU - Cho, Jin G.

AU - King, Meredith

AU - Roberts, Mary

AU - Kok, Cindy

AU - Jenkins, Christine

AU - Chow, Clara

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Introduction:Simple and scalable strategies are needed to improve a € out-of-hospital' support and management for people living with cardiovascular disease (CVD) and respiratory disease. Text messaging via mobile phones has been shown to be effective in helping promote lifestyle change and is supported by quantitative and qualitative evidence. The aim of this study is to test the effectiveness and implementation of a 6-month text messaging support programme for people with CVD and respiratory disease as an addition to cardiac and pulmonary outpatient rehabilitation.Methods and analysis:Pragmatic randomised controlled trial (n=310) to test the effectiveness of a 6-month text message support programme on clinical outcomes in people with CVD and chronic respiratory disease who are attending outpatient cardiac and pulmonary rehabilitation. The study includes a nested process evaluation to inform scalability and implementation across settings. The intervention group will receive a text message support programme comprising five messages per week for 26 weeks and the control group will continue with standard care. The primary outcome is exercise capacity (6 min walk distance). Secondary outcomes include clinical measures (proportion of people meeting the Australian guideline-recommended blood pressure and cholesterol targets), lifestyle outcomes (smoking rates, achievement of national guidelines for nutrition and physical activity), quality of life, mood (Hospital Anxiety and Depression Scale), medication adherence and attendance at and completion of rehabilitation. Ethics and dissemination:Primary ethics approval was received from the Sydney Local Health District Hospital Human Research Ethics Committee and associated Governance committees at sites. Results will be disseminated via the usual scientific forums including peer-reviewed publications and presentations at international conferences. At its conclusion, the study will determine the effectiveness and implementation of a simple programme that aims to improve health outcomes and attendance at rehabilitation for people with CVD and chronic respiratory disease. Trial registration number ACTRN12616001167459.

AB - Introduction:Simple and scalable strategies are needed to improve a € out-of-hospital' support and management for people living with cardiovascular disease (CVD) and respiratory disease. Text messaging via mobile phones has been shown to be effective in helping promote lifestyle change and is supported by quantitative and qualitative evidence. The aim of this study is to test the effectiveness and implementation of a 6-month text messaging support programme for people with CVD and respiratory disease as an addition to cardiac and pulmonary outpatient rehabilitation.Methods and analysis:Pragmatic randomised controlled trial (n=310) to test the effectiveness of a 6-month text message support programme on clinical outcomes in people with CVD and chronic respiratory disease who are attending outpatient cardiac and pulmonary rehabilitation. The study includes a nested process evaluation to inform scalability and implementation across settings. The intervention group will receive a text message support programme comprising five messages per week for 26 weeks and the control group will continue with standard care. The primary outcome is exercise capacity (6 min walk distance). Secondary outcomes include clinical measures (proportion of people meeting the Australian guideline-recommended blood pressure and cholesterol targets), lifestyle outcomes (smoking rates, achievement of national guidelines for nutrition and physical activity), quality of life, mood (Hospital Anxiety and Depression Scale), medication adherence and attendance at and completion of rehabilitation. Ethics and dissemination:Primary ethics approval was received from the Sydney Local Health District Hospital Human Research Ethics Committee and associated Governance committees at sites. Results will be disseminated via the usual scientific forums including peer-reviewed publications and presentations at international conferences. At its conclusion, the study will determine the effectiveness and implementation of a simple programme that aims to improve health outcomes and attendance at rehabilitation for people with CVD and chronic respiratory disease. Trial registration number ACTRN12616001167459.

UR - http://www.scopus.com/inward/record.url?scp=85062398036&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2018-023863

DO - 10.1136/bmjopen-2018-023863

M3 - Article

C2 - 30826759

AN - SCOPUS:85062398036

SN - 2044-6055

VL - 9

SP - 1

EP - 7

JO - BMJ Open

JF - BMJ Open

IS - 3

M1 - 023863

ER -

ITM support for patients with chronic respiratory and cardiovascular diseases: A protocol for a randomised controlled trial

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this